Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | TBXA2R | P21731 | 9/20 | 0.36 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.33 |
| ▸ | CDK2 | P24941 | 1/20 | 0.33 |
| ▸ | CCNA1 | P78396 | 1/20 | 0.33 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.33 |
| ▸ | CDK5R1 | Q15078 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29237236 | 0.81 | KMT2A (0.44) | KMT2AALDH1A1HTTSMN1; SMN2 | |
| SCHEMBL30967877 | 0.79 | KMT2A (0.39) | KMT2AALDH1A1HTTSMN1; SMN2 | |
| SCHEMBL9129362 | 0.78 | GSK3B (0.47) | KMT2A | |
| SCHEMBL30967862 | 0.77 | KMT2A (0.39) | KMT2AALDH1A1TBXA2R | |
| SCHEMBL29237402 | 0.77 | KMT2A (0.39) | KMT2AALDH1A1TBXA2R | |
| SCHEMBL29237381 | 0.77 | KMT2A (0.41) | KMT2AALDH1A1HTTSMN1; SMN2TBXA2R | |
| SCHEMBL30437369 | 0.75 | KMT2A (0.47) | KMT2AALDH1A1HTTSMN1; SMN2 | |
| SCHEMBL1339915 | 0.75 | KMT2A (0.47) | KMT2AALDH1A1HTTSMN1; SMN2 | |
| SCHEMBL2464708 | 0.73 | KMT2A (0.48) | KMT2AOPRK1 | |
| SCHEMBL5859196 | 0.73 | KMT2A (0.48) | KMT2AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118201919-A | Indole compounds and methods of use | 健赞公司 | 2024-06-14 | — | — | CN | disclosed |